Bio-Rad Laboratories is the famous Corporate Investor, which was founded in 1952. The leading representative office of defined Corporate Investor is situated in the Hercules. The company was established in North America in United States.
The important activity for fund was in 2006. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Health Diagnostics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Ciphergen Biosystems.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Bio-Rad Laboratories, startups are often financed by Amadeus Capital Partners. The meaningful sponsors for the fund in investment in the same round are Oxford Sciences Innovation.
Fund Name | Location |
Advanced MedTech Holdings (AMTH) | Central, Central Region, Singapore |
BHG Long Hills Capital | Beijing, Beijing, China |
Bonsai Partners | Community of Madrid, Madrid, Spain |
CDX Gas | Dallas, Texas, United States |
de Anda Capital | California, San Mateo, United States |
Hitron Technology | - |
Jiayi IEIG | - |
Kepha Partners | Massachusetts, United States, Waltham |
Oyster Funds | Luxembourg, Luxembourg |
Park Ten Capital | - |
Piramal Finance | - |
QB1 Ventures | New York, New York, United States |
Runnong Investment | China, Guangdong, Shenzhen |
Spacemob | Central, Central Region, Singapore |
Tennant Capital Partners | Missouri, Saint Louis, United States |
The Pacific Securities | China, Yunnan, Yünnan |
Vista Media Enterprises | - |
Zhongtong Yinglai Investment Management | Beijing, Beijing, China |
Zodius Capital | India, Maharashtra, Mumbai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$2M | 25 Jul 2016 | Oxford, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$2M | 25 Jul 2016 | Oxford, England, United Kingdom |